Literature DB >> 25114857

Current role of modern radiotherapy techniques in the management of breast cancer.

Gokhan Ozyigit1, Melis Gultekin1.   

Abstract

Breast cancer is the most common type of malignancy in females. Advances in systemic therapies and radiotherapy (RT) provided long survival rates in breast cancer patients. RT has a major role in the management of breast cancer. During the past 15 years several developments took place in the field of imaging and irradiation techniques, intensity modulated RT, hypofractionation and partial-breast irradiation. Currently, improvements in the RT technology allow us a subsequent decrease in the treatment-related complications such as fibrosis and long-term cardiac toxicity while improving the loco-regional control rates and cosmetic results. Thus, it is crucial that modern radiotherapy techniques should be carried out with maximum care and efficiency. Several randomized trials provided evidence for the feasibility of modern radiotherapy techniques in the management of breast cancer. However, the role of modern radiotherapy techniques in the management of breast cancer will continue to be defined by the mature results of randomized trials. Current review will provide an up-to-date evidence based data on the role of modern radiotherapy techniques in the management of breast cancer.

Entities:  

Keywords:  Breast cancer; Hypofractionation; Intensity modulated radiotherapy; Partial breast irradiation; Radiotherapy

Year:  2014        PMID: 25114857      PMCID: PMC4127613          DOI: 10.5306/wjco.v5.i3.425

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  102 in total

1.  Intensity-modulated tangential beam irradiation of the intact breast.

Authors:  L Hong; M Hunt; C Chui; S Spirou; K Forster; H Lee; J Yahalom; G J Kutcher; B McCormick
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

Review 2.  Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy.

Authors:  B A Fraass; M L Kessler; D L McShan; L H Marsh; B A Watson; W J Dusseau; A Eisbruch; H M Sandler; A S Lichter
Journal:  Semin Radiat Oncol       Date:  1999-01       Impact factor: 5.934

3.  The delivery of intensity modulated radiotherapy to the breast using multiple static fields.

Authors:  P M Evans; E M Donovan; M Partridge; P J Childs; D J Convery; S Eagle; V N Hansen; B L Suter; J R Yarnold
Journal:  Radiother Oncol       Date:  2000-10       Impact factor: 6.280

4.  Intensity modulation for breast treatment using static multi-leaf collimators.

Authors:  Y C Lo; G Yasuda; T J Fitzgerald; M M Urie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-01       Impact factor: 7.038

5.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

Authors:  J A van Dongen; A C Voogd; I S Fentiman; C Legrand; R J Sylvester; D Tong; E van der Schueren; P A Helle; K van Zijl; H Bartelink
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

6.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

7.  Cardiac and lung complication probabilities after breast cancer irradiation.

Authors:  C W Hurkmans; J H Borger; L J Bos; A van der Horst; B R Pieters; J V Lebesque; B J Mijnheer
Journal:  Radiother Oncol       Date:  2000-05       Impact factor: 6.280

8.  Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.

Authors:  A Katz; E A Strom; T A Buchholz; H D Thames; C D Smith; A Jhingran; G Hortobagyi; A U Buzdar; R Theriault; S E Singletary; M D McNeese
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

9.  Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.

Authors:  J Fisher; C Scott; R Stevens; B Marconi; L Champion; G M Freedman; F Asrari; M V Pilepich; J D Gagnon; G Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

10.  The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.

Authors:  C Vrieling; L Collette; A Fourquet; W J Hoogenraad; J H Horiot; J J Jager; M Pierart; P M Poortmans; H Struikmans; B Maat; E Van Limbergen; H Bartelink
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

View more
  4 in total

Review 1.  Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time?

Authors:  Tabitha Y Chan; Poh Wee Tan; Johann I Tang
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-03-20

2.  Collective radioresistance of T47D breast carcinoma cells is mediated by a Syncytin-1 homologous protein.

Authors:  Roberto Chignola; Michela Sega; Barbara Molesini; Anna Baruzzi; Sabrina Stella; Edoardo Milotti
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

3.  Comparison of long-term outcomes between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma.

Authors:  Hongbo Zhao; Kazuo Koyanagi; Ken Kato; Yoshinori Ito; Jun Itami; Hiroyasu Igaki; Yuji Tachimori
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

4.  Radiotherapy setup displacements in breast cancer patients: 3D surface imaging experience.

Authors:  Ana Cravo Sá; Ana Fermento; Dalila Neves; Sara Ferreira; Teresa Silva; Carina Marques Coelho; Aude Vaandering; Ana Roma; Sérgio Quaresma; Emmanuel Bonnarens
Journal:  Rep Pract Oncol Radiother       Date:  2018-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.